Cargando…
Oral Immunization of Mice with Cell Extracts from Recombinant Lactococcus lactis Expressing SARS-CoV-2 Spike Protein
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread all over the world and became a pandemic that named coronavirus disease-2019 (COVID-19). At present, several intramuscular vaccines have been successfully developed and mass vaccination has progressed in many countries. The aim...
Autores principales: | Xuan, Biao, Park, Jongbin, Yoo, Jeong Ho, Kim, Eun Bae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034443/ https://www.ncbi.nlm.nih.gov/pubmed/35460453 http://dx.doi.org/10.1007/s00284-022-02866-w |
Ejemplares similares
-
Oral Administration of Mice with Cell Extracts of Recombinant
Lactococcus lactis IL1403 Expressing Mouse Receptor
Activator of NF-kB Ligand (RANKL)
por: Xuan, Biao, et al.
Publicado: (2022) -
Oral immunization of mice with recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis virus spike glycoprotein
por: Tang, Lijie, et al.
Publicado: (2009) -
Expanding the recombinant protein quality in Lactococcus lactis
por: Cano-Garrido, Olivia, et al.
Publicado: (2014) -
Oral and intranasal immunization with food-grade recombinant Lactococcus lactis expressing high conserved region of SARS-CoV-2 spike protein triggers mice’s immunity responses
por: Yurina, Valentina, et al.
Publicado: (2023) -
The Effect of Recombinant Protein Production in Lactococcus lactis Transcriptome and Proteome
por: Monteiro, Gabriel A., et al.
Publicado: (2022)